Literature DB >> 24907204

Progressive intracranial hypertension and cerebral hypoperfusion in a fatal case of cerebral aspergilloma.

Linea Natalie Toksvang1, Ronni R Plovsing2, Ronan M G Berg1.   

Abstract

We report a case of cerebral aspergilloma in a 25-year-old immunoincompetent man admitted to a general intensive care unit. Monitoring of intracranial pressure was instigated and revealed hour-long epochs of severe intracranial hypertension, despite a normal opening pressure, with decreases in cerebral perfusion pressure. We documented that this was associated with cerebral hypoperfusion by transcranial Doppler ultrasound. The present case illustrates that severe intracranial hypertension may evolve despite a normal opening pressure; it furthermore shows that continuous monitoring of intracranial pressure may be used to predict changes in cerebral haemodynamics in critically ill patients with neuroinfection. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2014        PMID: 24907204      PMCID: PMC4054333          DOI: 10.1136/bcr-2013-201813

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  10 in total

Review 1.  Monitoring the injured brain: ICP and CBF.

Authors:  L A Steiner; P J D Andrews
Journal:  Br J Anaesth       Date:  2006-05-12       Impact factor: 9.166

2.  Multimodal cerebral monitoring and decompressive surgery for the treatment of severe bacterial meningitis with increased intracranial pressure.

Authors:  B Baussart; G Cheisson; M Compain; P E Leblanc; M Tadie; D Benhamou; J Duranteau
Journal:  Acta Anaesthesiol Scand       Date:  2006-07       Impact factor: 2.105

Review 3.  Utility of transcranial Doppler ultrasound for the integrative assessment of cerebrovascular function.

Authors:  C K Willie; F L Colino; D M Bailey; Y C Tzeng; G Binsted; L W Jones; M J Haykowsky; J Bellapart; S Ogoh; K J Smith; J D Smirl; T A Day; S J Lucas; L K Eller; P N Ainslie
Journal:  J Neurosci Methods       Date:  2011-01-27       Impact factor: 2.390

4.  Invasive mold infections in allogeneic bone marrow transplant recipients.

Authors:  J W Baddley; T P Stroud; D Salzman; P G Pappas
Journal:  Clin Infect Dis       Date:  2001-04-13       Impact factor: 9.079

5.  Effect of intracranial pressure monitoring and targeted intensive care on functional outcome after severe head injury.

Authors:  Olaf L Cremer; Gert W van Dijk; Erik van Wensen; Geert J F Brekelmans; Karel G M Moons; Loek P H Leenen; Cor J Kalkman
Journal:  Crit Care Med       Date:  2005-10       Impact factor: 7.598

6.  Concepts of cerebral perfusion pressure and vascular compression during intracranial hypertension.

Authors:  J D Miller; A Stanek; T W Langfitt
Journal:  Prog Brain Res       Date:  1972       Impact factor: 2.453

7.  Invasive central nervous system aspergillosis in bone marrow transplantation recipients: an overview.

Authors:  Ali Guermazi; Eliane Gluckman; Bachir Tabti; Yves Miaux
Journal:  Eur Radiol       Date:  2002-06-28       Impact factor: 5.315

Review 8.  Advances in ICP monitoring techniques.

Authors:  Jun Zhong; Manuel Dujovny; Hun K Park; Eimir Perez; Alfred R Perlin; Fernando G Diaz
Journal:  Neurol Res       Date:  2003-06       Impact factor: 2.448

Review 9.  Central nervous system aspergillosis: a series of 14 cases from a general hospital and review of 123 cases from the literature.

Authors:  Themistoklis K Kourkoumpetis; Athanasios Desalermos; Maged Muhammed; Eleftherios Mylonakis
Journal:  Medicine (Baltimore)       Date:  2012-11       Impact factor: 1.889

10.  Aspergillosis of the central nervous system: clinicopathological analysis of 17 patients.

Authors:  T J Walsh; D B Hier; L R Caplan
Journal:  Ann Neurol       Date:  1985-11       Impact factor: 10.422

  10 in total
  1 in total

1.  Soluble ectodomain CD163 and extracellular vesicle-associated CD163 are two differently regulated forms of 'soluble CD163' in plasma.

Authors:  Anders Etzerodt; Ronan M G Berg; Ronni R Plovsing; Morten N Andersen; Magali Bebien; Mohamed Habbeddine; Toby Lawrence; Holger J Møller; Søren K Moestrup
Journal:  Sci Rep       Date:  2017-01-13       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.